Sign In

CPS mobile app now available for CMA members

CMA members can now download a new valuable electronic point-of-care tool — the RxTx Mobile App, at no charge.

Through this app, practising and resident members can access the well-known Compendium of Pharmaceuticals and Specialties (CPS) - aka the “big blue book” - published by the Canadian Pharmacists Association (CPhA).

Effective this year, the CPhA will no longer distribute a free print edition of the CPS so the new app provides an opportunity for eligible members to continue to access this valuable and relevant clinical tool. According to the 2013 PMB Medical Media Study three-quarters of Canadian physicians refer to the CPS regularly and have rated it 4.5 out of 5 as a valuable drug reference.

The RxTx Mobile App – which also provides access to Drug Choices (Tx) as a bonus – contains searchable product monographs for drugs, vaccines and natural health products, prepared by the pharmaceutical manufacturers and approved by Health Canada. Physicians can also check doses, adverse effects, drug interactions and relative cost of over 2200 drugs for over 200 medical conditions.

This information is updated regularly and available in English and French on iOS and Android devices.

“Up-to-date information on pharmaceuticals is critical to much of the work physicians do,” said CMA President Chris Simpson. “Having such a well-known resource as the CPS available as an app will be a real benefit to CMA members who are increasingly working in a mobile environment.”

“Prescribing information changes rapidly in today’s world. The RxTx Mobile App makes it easier and faster to make the right choices throughout a busy day in clinic,” said Dr. Javed Alloo, a Toronto family physician.

All eligible CMA members should have received a personal email on how to download the app, valued at $500 – more than the cost of the annual CMA membership fee.

Any members with questions about the RxTx Mobile App can contact the CMA Member Service Centre at 844-748-8017 (weekdays, 8 a.m. to 8 p.m. ET) or

Forward any comments about this article to: